Ryan J Asby
6PUBLICATIONS
48CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jun 25, 2025
Posttranscriptional depletion of ribosome biogenesis factors engenders therapeutic vulnerabilities in NPM1-mutant AML.Aristi Damaskou, Rachael Wilson, Malgorzata Gozdecka
|Oct 07, 2024
Maintenance of hematopoietic stem cells by tyrosine-unphosphorylated STAT5 and JAK inhibition.Matthew J Williams, Xiaonan Wang, Hugo P Bastos
|Aug 03, 2022
Transcriptional variability accelerates preleukemia by cell diversification and perturbation of protein synthesis.Shikha Gupta, Oliver M Dovey, Ana Filipa Domingues
|Feb 08, 2022
Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma.Georgina S F Anderson, Jose Ballester-Beltran, George Giotopoulos
|Oct 15, 2021
KAT2A complexes ATAC and SAGA play unique roles in cell maintenance and identity in hematopoiesis and leukemia.Liliana Arede, Elena Foerner, Selinde Wind
|Mar 21, 2019
Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML.Faisal Basheer, George Giotopoulos, Eshwar Meduri
Pageof 1
Frequent Collaborators
5 joint publications
George Giotopoulos
5 joint publications
Brian Jp Huntly
4 joint publications
George S Vassiliou
2 joint publications
Cristina Pina
1 joint publications
Paolo Gallipoli
1 joint publications
Hartmut Döhner
1 joint publications
Selinde Wind
1 joint publications
Laszlo Tora
1 joint publications
Georgina S F Anderson
1 joint publications
Jose Ballester-Beltran
